Afdilla F, Hwang W, Yukawa M
Methods Mol Biol. 2024; 2862:333-351.
PMID: 39527212
DOI: 10.1007/978-1-0716-4168-2_24.
Yang S, Zhao Y, Tan Y, Zheng C
Heliyon. 2024; 10(11):e31853.
PMID: 38868049
PMC: 11168324.
DOI: 10.1016/j.heliyon.2024.e31853.
Gao W, Lu J, Yang Z, Li E, Cao Y, Xie L
Biomolecules. 2024; 14(4).
PMID: 38672404
PMC: 11047945.
DOI: 10.3390/biom14040386.
Elseginy S
J Comput Aided Mol Des. 2024; 38(1):16.
PMID: 38556596
PMC: 10982093.
DOI: 10.1007/s10822-024-00553-5.
Chen D, Wang J, Li Y, Xu C, Fanzheng M, Zhang P
Clin Transl Med. 2023; 13(9):e1418.
PMID: 37752791
PMC: 10522973.
DOI: 10.1002/ctm2.1418.
TRAF4 Inhibits the Apoptosis and Promotes the Proliferation of Breast Cancer Cells by Inhibiting the Ubiquitination of Spindle Assembly-Associated Protein Eg5.
Hao M, Zhang J, Sun M, Diao K, Wang J, Li S
Front Oncol. 2022; 12:855139.
PMID: 35692762
PMC: 9174544.
DOI: 10.3389/fonc.2022.855139.
Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
Shi H, Xu H, Chai C, Qin Z, Zhou W
J Clin Lab Anal. 2022; 36(5):e24381.
PMID: 35403252
PMC: 9102654.
DOI: 10.1002/jcla.24381.
NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation.
Zheng J, Tan Y, Liu X, Zhang C, Su K, Jiang Y
Cell Death Differ. 2022; 29(4):846-860.
PMID: 35210604
PMC: 8989979.
DOI: 10.1038/s41418-021-00899-5.
Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 Inhibitors in a Gastric Adenocarcinoma In Vitro Model.
Ricci A, Gallorini M, Del Bufalo D, Cataldi A, DAgostino I, Carradori S
Molecules. 2022; 27(3).
PMID: 35164221
PMC: 8840372.
DOI: 10.3390/molecules27030957.
Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer.
Neska-Dlugosz I, Buchholz K, Durslewicz J, Gagat M, Grzanka D, Tojek K
Int J Mol Sci. 2021; 22(18).
PMID: 34575892
PMC: 8466126.
DOI: 10.3390/ijms22189732.
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers.
Murase Y, Ono H, Ogawa K, Yoshioka R, Ishikawa Y, Ueda H
Cancer Sci. 2021; 112(11):4641-4654.
PMID: 34510663
PMC: 8586681.
DOI: 10.1111/cas.15134.
Second-Generation Antimitotics in Cancer Clinical Trials.
Novais P, Silva P, Amorim I, Bousbaa H
Pharmaceutics. 2021; 13(7).
PMID: 34371703
PMC: 8309102.
DOI: 10.3390/pharmaceutics13071011.
Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma.
Klimaszewska-Wisniewska A, Neska-Dlugosz I, Buchholz K, Durslewicz J, Grzanka D, Kasperska A
Cancers (Basel). 2021; 13(12).
PMID: 34208606
PMC: 8234517.
DOI: 10.3390/cancers13123017.
Mechanisms by Which Kinesin-5 Motors Perform Their Multiple Intracellular Functions.
Pandey H, Popov M, Goldstein-Levitin A, Gheber L
Int J Mol Sci. 2021; 22(12).
PMID: 34203964
PMC: 8232732.
DOI: 10.3390/ijms22126420.
KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.
Hu Z, Jiang Y, Sun H, Wang J, Zhai L, Yin Z
Biomed Res Int. 2021; 2021:2676745.
PMID: 33490265
PMC: 7801104.
DOI: 10.1155/2021/2676745.
Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Chen X, Liao L, Li Y, Huang H, Huang Q, Deng S
Biomed Res Int. 2020; 2020:7653506.
PMID: 33102593
PMC: 7568806.
DOI: 10.1155/2020/7653506.
Age-related differences in the translational landscape of mammalian oocytes.
Del Llano E, Masek T, Gahurova L, Pospisek M, Koncicka M, Jindrova A
Aging Cell. 2020; 19(10):e13231.
PMID: 32951297
PMC: 7576272.
DOI: 10.1111/acel.13231.
Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
Bai Y, Wang X, Hou J, Geng L, Liang X, Ruan Z
Front Genet. 2020; 11:899.
PMID: 32849853
PMC: 7427512.
DOI: 10.3389/fgene.2020.00899.
Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.
Wang B, Yu J, Sun Z, Luh F, Lin D, Shen Y
Mol Carcinog. 2020; 59(8):908-922.
PMID: 32346924
PMC: 7384136.
DOI: 10.1002/mc.23203.
Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment.
Marconi G, Carradori S, Ricci A, Guglielmi P, Cataldi A, Zara S
Molecules. 2019; 24(21).
PMID: 31683688
PMC: 6864856.
DOI: 10.3390/molecules24213948.